Literature DB >> 8546699

Transglutaminase induced by epidermal growth factor negatively regulates the growth signal in primary cultured hepatocytes.

S Katoh1, N Nakagawa, Y Yano, K Satoh, H Kohno, Y Ohkubo.   

Abstract

Transglutaminase (TGase) activity increased 2.5-fold at 6 h after treatment of rat hepatocytes with 17 nM epidermal growth factor (EGF). In the same manner, putrescine incorporation into the proteins of cells occurred in EGF-treated cells, but not in those pretreated with monodansylcadaverine (MDC), a TGase inhibitor, even in the presence of EGF. These results suggest that EGF-induced TGase was active and catalysed some cross-linkage reaction. Cycloheximide completely blocked the increase in TGase activity induced by EGF, suggesting that EGF stimulated de novo synthesis of TGase within 6 h. Furthermore, Northern blotting analysis indicated that EGF increased the expression of TGase mRNA. Pretreatment of cells with MDC additionally increased EGF-induced DNA-synthesis and the ratio of cells in S-phase. TGase antisense oligonucleotide inhibited de novo synthesis of TGase, resulting in increases in the ratios of S- and G2/M-phase cells in the presence of EGF. This effect was the result of inhibition of EGF-induced down-regulation of high-affinity receptor expression. These results suggest that the EGF-induced increase in TGase activity is a negative regulator of a growth signal in rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546699      PMCID: PMC1216898          DOI: 10.1042/bj3130305

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Interaction of epidermal growth factor receptors with the cytoskeleton is related to receptor clustering.

Authors:  N van Belzen; M Spaargaren; A J Verkleij; J Boonstra
Journal:  J Cell Physiol       Date:  1990-11       Impact factor: 6.384

2.  "Tissue" transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation.

Authors:  M Piacentini; F Autuori; L Dini; M G Farrace; L Ghibelli; L Piredda; L Fesus
Journal:  Cell Tissue Res       Date:  1991-02       Impact factor: 5.249

Review 3.  Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues.

Authors:  C S Greenberg; P J Birckbichler; R H Rice
Journal:  FASEB J       Date:  1991-12       Impact factor: 5.191

4.  Enzymatic labelling of actin and tropomyosin with 14 C-labelled putrescine.

Authors:  N Derrick; K Laki
Journal:  Biochem Biophys Res Commun       Date:  1966-01-04       Impact factor: 3.575

5.  Ligand-induced association of epidermal growth factor receptor to the cytoskeleton of A431 cells.

Authors:  P M van Bergen en Henegouwen; L H Defize; J de Kroon; H van Damme; A J Verkleij; J Boonstra
Journal:  J Cell Biochem       Date:  1989-04       Impact factor: 4.429

6.  The epidermal growth factor receptor is associated with actin filaments.

Authors:  P M van Bergen en Henegouwen; J C den Hartigh; P Romeyn; A J Verkleij; J Boonstra
Journal:  Exp Cell Res       Date:  1992-03       Impact factor: 3.905

7.  Internalization model using rat liver plasma membrane for receptor-mediated endocytosis of epidermal growth factor.

Authors:  S Katoh; J Midorikami; H Kohno; Y Ohkubo
Journal:  Chem Pharm Bull (Tokyo)       Date:  1991-12       Impact factor: 1.645

8.  Epidermal growth factor treatment of A431 cells alters the binding capacity and electrophoretic mobility of the cytoskeletally associated epidermal growth factor receptor.

Authors:  L M Roy; C K Gittinger; G E Landreth
Journal:  J Cell Physiol       Date:  1991-01       Impact factor: 6.384

9.  High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses.

Authors:  F Bellot; W Moolenaar; R Kris; B Mirakhur; I Verlaan; A Ullrich; J Schlessinger; S Felder
Journal:  J Cell Biol       Date:  1990-02       Impact factor: 10.539

10.  Epidermal growth factor induces rapid reorganization of the actin microfilament system in human A431 cells.

Authors:  P J Rijken; W J Hage; P M van Bergen en Henegouwen; A J Verkleij; J Boonstra
Journal:  J Cell Sci       Date:  1991-11       Impact factor: 5.285

View more
  5 in total

1.  Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells.

Authors:  Carla Esposito; Monica Marra; Gaia Giuberti; Anna Maria D'Alessandro; Raffaele Porta; Anna Cozzolino; Michele Caraglia; Alberto Abbruzzese
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

2.  Alteration of enzymatic activities implicating neuronal degeneration in the spinal cord of the motor neuron degeneration mouse during postnatal development.

Authors:  K Fujita; K Shibayama; M Yamauchi; T Kato; M Ando; H Takahashi; K Iritani; N Yoshimoto; Y Nagata
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

3.  Transglutaminase differentially regulates growth signalling in rat perivenous and periportal hepatocytes.

Authors:  A Maruko; Y Ohtake; K Konno; S Abe; Y Ohkubo
Journal:  Cell Prolif       Date:  2006-06       Impact factor: 6.831

4.  Transglutaminase down-regulates the dimerization of epidermal growth factor receptor in rat perivenous and periportal hepatocytes.

Authors:  A Maruko; Y Ohtake; S Katoh; Y Ohkubo
Journal:  Cell Prolif       Date:  2009-07-09       Impact factor: 6.831

Review 5.  Post-translational modification and regulation of actin.

Authors:  Jonathan R Terman; Anna Kashina
Journal:  Curr Opin Cell Biol       Date:  2012-11-27       Impact factor: 8.382

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.